Analytics for Earnings Momentum Keeps Express Scripts (ESRX) a Sell

Currently, Express Scripts Holdings Co (NASDAQ:ESRX) has a Sell using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. The current Portfolio Grader recommendation on the shares has been in place for 11 months.

The company ranks in the top 10% of its industry group, Health Care Providers & Services, and in the top 10% of its sector group, Health Care, with a market value of $34.4 billion.

Currently, Portfolio Grader ranks the Health Care sector number 10 among the 12 sectors in its universe putting it in the bottom quartile of all the GICS sectors. The Health Care Providers & Services industry group is ranked 48 among the 69 industry groups within the GICS sectors, placing it below-average in terms of the Navellier scoring system.

The company scores are below-average in 4 of the 8 fundamental metrics used by Portfolio Grader in the ranking of company stocks.

The company's operational scores provide mixed results with rankings for operating margin and earnings growth that are above average, while the score for sales growth is below average. Scores for visibility of earnings are worse than the industry norms for earnings revisions, earnings surprises, and earnings momentum. ESRX's metrics for return on equity and cash flow are materially better than its industry group average. These fundamental scores give Express Scripts a position in the top half of the industry group.

The Navellier Proprietary Quantitative Score is used by Portfolio Grader to measure ESRX's shares from the viewpoint of risk/reward. This exclusive scoring system balances the relative value of ESRX's shares based on the current price of the shares relative to its peers, the market and risk associated with its industry and sector groups. Based on this risk/reward calculation, the company currently scores well below-average in its industry group compared to its peers.

Louis Navellier's proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results, with A being 'strong buy' and F being 'strong sell'. Explore the tool here.

Commentary provided by UpTick Data Technologies.


Article printed from InvestorPlace Media, https://investorplace.com/2017/10/analytics-for-earnings-momentum-keeps-express-scripts-esrx-a-sell/.

©2026 InvestorPlace Media, LLC